Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3.13% is 59% above its 5-year average of 1.97%, around the middle of its 5-year range (-9.54%–9.89%).
7.94% above its 12-month average of 2.90%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.78%.
NET PROFIT MARGIN
3.13%
NET PROFIT MARGIN AVG TTM
2.90%
NET PROFIT MARGIN AVG 3Y
1.58%
NET PROFIT MARGIN AVG 5Y
1.97%
NET PROFIT MARGIN AVG 10Y
2.85%
NET PROFIT MARGIN AVG 15Y
4.15%
NET PROFIT MARGIN AVG 20Y
4.17%
CURRENT VS TTM AVG
+7.94%
CURRENT VS 3Y AVG
+98.50%
CURRENT VS 5Y AVG
+58.89%
CURRENT VS 10Y AVG
+9.83%
CURRENT VS 15Y AVG
-24.56%
CURRENT VS 20Y AVG
-25.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$1.61B
Net Profit Margin
-140.43%
TTM Avg
-164.31%
3Y Avg
-442.76%
5Y Avg
-354.21%
Market Cap
$1.63B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
Market Cap
$1.63B
Net Profit Margin
-579.10%
TTM Avg
-408.42%
3Y Avg
-273.23%
5Y Avg
-333.72%
Market Cap
$1.65B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
Market Cap
$1.54B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
Market Cap
$1.54B
Net Profit Margin
-1350.73%
TTM Avg
-1059.67%
3Y Avg
-1046.38%
5Y Avg
-742.65%
Market Cap
$1.54B
Net Profit Margin
21.25%
TTM Avg
9.48%
3Y Avg
-48.31%
5Y Avg
-19.09%
Market Cap
$1.51B
Net Profit Margin
12.02%
TTM Avg
-7.78%
3Y Avg
-15.24%
5Y Avg
-11964.64%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omnicell, Inc. (OMCL) | $1.60B | 3.13% | 2.90% | 1.58% | 1.97% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | -140.43% | -164.31% | -442.76% | -354.21% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 10.82% | 2.93% | -1.36% | -5.99% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.63B | -579.10% | -408.42% | -273.23% | -333.72% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -13.50% | -22.64% | -31.77% | -40.07% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 80.56% | 35.15% | 48.19% | 54.54% |
| uniQure N.V. (QURE)vs › | $1.54B | -1350.73% | -1059.67% | -1046.38% | -742.65% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 21.25% | 9.48% | -48.31% | -19.09% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 12.02% | -7.78% | -15.24% | -11964.64% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 6.57% | 5.15% | 3.47% | 4.27% |
Operating Margin
4.7%
Net Profit Margin
3.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.78% |
| 2026-03-31 | 3.67% |
| 2025-12-31 | -0.65% |
| 2025-09-30 | 1.76% |
| 2025-06-30 | 1.94% |
| 2025-03-31 | -2.60% |
| 2024-12-31 | 5.16% |
| 2024-09-30 | 3.06% |
| 2024-06-30 | 1.35% |
| 2024-03-31 | -6.37% |
| 2023-12-31 | -5.55% |
| 2023-09-30 | 1.86% |
| 2023-06-30 | 1.15% |
| 2023-03-31 | -5.16% |
| 2022-12-31 | -9.54% |
| 2022-09-30 | 4.82% |
| 2022-06-30 | 2.74% |
| 2022-03-31 | 2.58% |
| 2021-12-31 | 4.50% |
| 2021-09-30 | 9.89% |
| 2021-06-30 | 7.49% |
| 2021-03-31 | 5.61% |
| 2020-12-31 | 6.57% |
| 2020-09-30 | 4.12% |
| 2020-06-30 | -2.15% |
| 2020-03-31 | 4.92% |
| 2019-12-31 | 8.90% |
| 2019-09-30 | 8.73% |
| 2019-06-30 | 7.35% |
| 2019-03-31 | 1.62% |
| 2018-12-31 | 6.99% |
| 2018-09-30 | 6.67% |
| 2018-06-30 | 3.49% |
| 2018-03-31 | 1.49% |
| 2017-12-31 | 12.27% |
| 2017-09-30 | 4.15% |
| 2017-06-30 | 0.46% |
| 2017-03-31 | -7.14% |
| 2016-12-31 | 0.09% |
| 2016-09-30 | 1.12% |
| 2016-06-30 | -0.67% |
| 2016-03-31 | -0.22% |
| 2015-12-31 | 5.87% |
| 2015-09-30 | 6.42% |
| 2015-06-30 | 7.76% |
| 2015-03-31 | 5.44% |
| 2014-12-31 | 7.60% |
| 2014-09-30 | 6.49% |
| 2014-06-30 | 7.41% |
| 2014-03-31 | 6.09% |
| 2013-12-31 | 6.45% |
| 2013-09-30 | 8.25% |
| 2013-06-30 | 6.42% |
| 2013-03-31 | 3.89% |
| 2012-12-31 | 6.14% |
| 2012-09-30 | 8.21% |
| 2012-06-30 | 1.82% |
| 2012-03-31 | 3.67% |
| 2011-12-31 | 6.58% |
| 2011-09-30 | 4.65% |
| 2011-06-30 | 4.24% |
| 2011-03-31 | 1.17% |
| 2010-12-31 | 1.17% |
| 2010-09-30 | 2.27% |
| 2010-06-30 | 3.59% |
| 2010-03-31 | 1.81% |
| 2009-12-31 | 1.02% |
| 2009-09-30 | 1.58% |
| 2009-06-30 | 1.72% |
| 2009-03-31 | -3.58% |
| 2008-12-31 | 5.35% |
| 2008-09-30 | 4.53% |
| 2008-06-30 | 4.34% |
| 2008-03-31 | 6.01% |
| 2007-12-31 | 24.67% |
| 2007-09-30 | 12.58% |
| 2007-06-30 | 34.91% |
| 2007-03-31 | 8.23% |
| 2006-12-31 | 11.18% |
| 2006-09-30 | 7.61% |
| 2006-06-30 | 5.93% |
| 2006-03-31 | 3.00% |
| 2005-12-31 | 6.68% |
| 2005-09-30 | 4.61% |
| 2005-06-30 | 0.23% |
| 2005-03-31 | -20.15% |
| 2004-12-31 | 7.66% |
| 2004-09-30 | 9.95% |
| 2004-06-30 | 8.12% |
| 2004-03-31 | 8.46% |
| 2003-12-31 | 11.36% |
| 2003-09-30 | 8.83% |
| 2003-06-30 | 5.14% |
| 2003-03-31 | 2.01% |
| 2002-12-31 | -30.55% |
| 2002-09-30 | -13.55% |
